Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1980 Aug;66(2):306–313. doi: 10.1172/JCI109858

Supersensitivity of Atherosclerotic Rabbit Aorta to Ergonovine

MEDIATION BY A SEROTONERGIC MECHANISM

Philip D Henry 1, Mitsuhiro Yokoyama 1
PMCID: PMC371712  PMID: 7400317

Abstract

Patients with coronary vasospasm appear to be supersensitive to the coronary constrictor effects of ergonovine. To determine whether atherosclerosis alters arterial reactivity and sensitizes arteries to ergonovine, contractile responses of isolated aortae from control rabbits and from rabbits fed a high-cholesterol diet were compared. Aortic strips were mounted in a myograph for the monitoring of isometric tension, equilibrated in oxygenated Krebs buffer, and exposed to graded concentrations of agonists and antagonists. The concentration-response relation for ergonovine in atherosclerotic arteries exhibited a markedly depressed constrictor threshold concentration (0.5 pM vs. 0.23 μM in controls), a significantly lowered one-half effective dose (ED50) value, and an augmented maximal response. Furthermore, atherosclerotic arteries showed similar, although less pronounced changes in the concentration-response relation for serotonin. In contrast, responses to 34 mM KCl were virtually identical, and the concentration-response relation for phenylephrine were similar in the two groups. In control arteries, 0.1 μM phentolamine and 0.1 μM prazosin suppressed responses to 1 μM ergonovine by 71 and 90%, respectively. However, in atherosclerotic arteries α-blockers in the same concentration inhibited responses to 0.01 μM ergonovine by less than 10%. On the other hand, 0.1 μM cyproheptadine, a serotonergic antagonist, suppressed these responses by 82%. Thus, the supersensitivity to ergonovine appeared to be mediated predominantly by a serotonergic mechanism. These results indicate that smooth muscle in atherosclerotic arteries may be supersensitive to specific vasoconstricting stimuli, a change that might contribute to arterial dysfunction in vivo.

Full text

PDF
306

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angoli L., Marinoni G. P., Falcone C., Bramucci E., de Servi S., Specchia G., Montemartini C. Spasme coronarien à l'effort. Démonstration coronarographique d'un cas. Arch Mal Coeur Vaiss. 1978 Jul;71(7):823–826. [PubMed] [Google Scholar]
  2. Apperley E., Humphrey P. P., Levy G. P. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol. 1976 Oct;58(2):211–221. doi: 10.1111/j.1476-5381.1976.tb10398.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borda L., Shuchleib R., Henry P. D. Effects of potassium on isolated canine coronary arteries. Modulation of adrenergic responsiveness and release of norepinephrine. Circ Res. 1977 Dec;41(6):778–786. doi: 10.1161/01.res.41.6.778. [DOI] [PubMed] [Google Scholar]
  4. Broustet J. P., Griffo R., Seriès E., Guern P., Laylavoix F. Angor de Prinzmetal déclenché par l'arrêt de l'effort. Cinq cas à coronarographie normale. Arch Mal Coeur Vaiss. 1979 Apr;72(4):391–400. [PubMed] [Google Scholar]
  5. Chan C. T., Wells H., Kramsch D. M. Suppression of calcific fibrous-fatty plaque formation in rabbits by agents not affecting elevated serum cholesterol levels. The effect of thiophene compounds. Circ Res. 1978 Jul;43(1):115–125. doi: 10.1161/01.res.43.1.115. [DOI] [PubMed] [Google Scholar]
  6. Collis M. G., Vanhoutte P. M. Vascular reactivity of isolated perfused kidneys from male and female spontaneously hypertensive rats. Circ Res. 1977 Dec;41(6):759–767. doi: 10.1161/01.res.41.6.759. [DOI] [PubMed] [Google Scholar]
  7. Constantine J. W., McShane W. K., Scriabine A., Hess H. J. Analysis of the hypotensive action of prazosin. Postgrad Med. 1975 Nov;Spec No:18–35. [PubMed] [Google Scholar]
  8. Curry R. C., Jr, Pepine C. J., Sabom M. B., Conti C. R. Similarities of ergonovine-induced and spontaneous attacks of variant angina. Circulation. 1979 Feb;59(2):307–312. doi: 10.1161/01.cir.59.2.307. [DOI] [PubMed] [Google Scholar]
  9. Dembinska-Kiec A., Gryglewska T., Zmuda A., Gryglewski R. J. The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits. Prostaglandins. 1977;14(6):1025–1034. doi: 10.1016/0090-6980(77)90282-9. [DOI] [PubMed] [Google Scholar]
  10. Doxey J. C., Smith C. F., Walker J. M. Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors. Br J Pharmacol. 1977 May;60(1):91–96. doi: 10.1111/j.1476-5381.1977.tb16752.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. FURCHGOTT R. F., BHADRAKOM S. Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther. 1953 Jun;108(2):129–143. [PubMed] [Google Scholar]
  12. Fuller R. W., Wong D. T. Inhibition of serotonin reuptake. Fed Proc. 1977 Jul;36(8):2154–2158. [PubMed] [Google Scholar]
  13. Gamble W., Vaughan M., Kruth H. S., Avigan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res. 1978 Nov;19(8):1068–1070. [PubMed] [Google Scholar]
  14. Gryglewski R. J., Dembińska-Kiè A., Zmuda A., Gryglewska T. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis. 1978 Dec;31(4):385–394. doi: 10.1016/0021-9150(78)90133-8. [DOI] [PubMed] [Google Scholar]
  15. Heupler F. A., Jr, Proudfit W. L., Razavi M., Shirey E. K., Greenstreet R., Sheldon W. C. Ergonovine maleate provocative test for coronary arterial spasm. Am J Cardiol. 1978 Apr;41(4):631–640. doi: 10.1016/0002-9149(78)90810-x. [DOI] [PubMed] [Google Scholar]
  16. Kimelberg H. K., Papahadjopoulos D. Effects of phospholipid acyl chain fluidity, phase transitions, and cholesterol on (Na+ + K+)-stimulated adenosine triphosphatase. J Biol Chem. 1974 Feb 25;249(4):1071–1080. [PubMed] [Google Scholar]
  17. Klein I., Moore L., Pastan I. Effect of liposomes containing cholesterol on adenylate cyclase activity of cultured mammalian fibroblasts. Biochim Biophys Acta. 1978 Jan 4;506(1):42–53. doi: 10.1016/0005-2736(78)90433-9. [DOI] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Lais L. T., Brody M. J. Mechanism of vascular hyperresponsiveness in the spontaneously hypertensive rat. Circ Res. 1975 Jun;36(6 Suppl 1):216–222. doi: 10.1161/01.res.36.6.216. [DOI] [PubMed] [Google Scholar]
  20. Maseri A., Severi S., Nes M. D., L'Abbate A., Chierchia S., Marzilli M., Ballestra A. M., Parodi O., Biagini A., Distante A. "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol. 1978 Dec;42(6):1019–1035. doi: 10.1016/0002-9149(78)90691-4. [DOI] [PubMed] [Google Scholar]
  21. McLaughlin P. R., Doherty P. W., Martin R. P., Goris M. L., Harrison D. C. Myocardial imaging in a patient with reproducible variant angina. Am J Cardiol. 1977 Jan;39(1):126–129. doi: 10.1016/s0002-9149(77)80023-4. [DOI] [PubMed] [Google Scholar]
  22. Müller-Schweinitzer E., Brundell J. Enhanced prostaglandin synthesis contributes to the venoconstrictor activity of ergotamine. Blood Vessels. 1975;12(4):193–205. doi: 10.1159/000158056. [DOI] [PubMed] [Google Scholar]
  23. Müller-Schweinitzer E. Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine. Naunyn Schmiedebergs Arch Pharmacol. 1976 Oct;295(1):41–44. doi: 10.1007/BF00509770. [DOI] [PubMed] [Google Scholar]
  24. Müller-Schweinitzer E. Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine. Naunyn Schmiedebergs Arch Pharmacol. 1976;292(2):113–118. doi: 10.1007/BF00498580. [DOI] [PubMed] [Google Scholar]
  25. Müller-Schweinitzer E., Stürmer E. Studies on the mechanism of the venoconstrictor activity of ergotamine on isolated canine saphenous veins. Blood Vessels. 1974;11(3):183–190. doi: 10.1159/000158011. [DOI] [PubMed] [Google Scholar]
  26. Oliva P. B. Role of coronary arterial spasm in ischemic heart disease. Adv Cardiol. 1978;(22):164–174. doi: 10.1159/000401027. [DOI] [PubMed] [Google Scholar]
  27. Papahadjopoulos D., Cowden M., Kimelberg H. Role of cholesterol in membranes. Effects on phospholipid-protein interactions, membrane permeability and enzymatic activity. Biochim Biophys Acta. 1973 Nov 30;330(1):8–26. doi: 10.1016/0005-2736(73)90280-0. [DOI] [PubMed] [Google Scholar]
  28. Small D. M., Shipley G. G. Physical-chemical basis of lipid deposition in atherosclerosis. Science. 1974 Jul 19;185(4147):222–229. doi: 10.1126/science.185.4147.222. [DOI] [PubMed] [Google Scholar]
  29. Specchia G., de Servi S., Falcone C., Bramucci E., Angoli L., Mussini A., Marinoni G. P., Montemartini C., Bobba P. Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina. Circulation. 1979 May;59(5):948–954. doi: 10.1161/01.cir.59.5.948. [DOI] [PubMed] [Google Scholar]
  30. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  31. Waters D. D., Chaitman B. R., Dupras G., Théroux P., Mizgala H. F. Coronary artery spasm during exercise in patients with variant angina. Circulation. 1979 Mar;59(3):580–585. doi: 10.1161/01.cir.59.3.580. [DOI] [PubMed] [Google Scholar]
  32. Wikberg J. Differentiation between pre- and postjunctional alpha-receptors in guinea pig ileum and rabbit aorta. Acta Physiol Scand. 1978 Jul;103(3):225–239. doi: 10.1111/j.1748-1716.1978.tb06210.x. [DOI] [PubMed] [Google Scholar]
  33. Yasue H., Omote S., Takizawa A., Nagao M., Miwa K., Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise-induced coronary arterial spasm. Circulation. 1979 May;59(5):938–948. doi: 10.1161/01.cir.59.5.938. [DOI] [PubMed] [Google Scholar]
  34. Yasue H., Omote S., Takizawa A., Nagao M., Miwa K., Tanaka S. Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. Am J Cardiol. 1979 Mar;43(3):647–652. doi: 10.1016/0002-9149(79)90026-2. [DOI] [PubMed] [Google Scholar]
  35. Yokoyama M., Henry P. D. Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol. Circ Res. 1979 Oct;45(4):479–486. doi: 10.1161/01.res.45.4.479. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES